Navigation Links
Free Download -- Two impressive case studies on Pharmaceutical Intellectual Property
Date:9/18/2013

SHANGHAI, Sept. 18, 2013 /PRNewswire/ -- Organized by CPhI Conferences and UBM Conferences, 2013 Pharmaceutical Intellectual Property Forum will take place on 27th-28th November at Sheraton HongKou, Shanghai. This forum will deliver themes which will optimize IP strategy. This conference aims to provide a platform to facilitate exchange of experience, and encourage more cooperation between Pharmaceutical & Biotech Companies, Law firms and IP Agencies. It will walk away with fresh insights, tactics and tools to apply for patents, strategize litigation techniques and remain competitive in today's constantly changing patent landscape. Hear from experts, meet potential collaborators and gather insights to re-align IP strategy. To download full agenda, please click to www.pharmaip-forum.com.

(Photo: http://www.prnasia.com/sa/2013/09/17/20130917164117965549.html )

Meanwhile, the organizer shared with us with two excellent presentations about pharmaceutical intellectual property. One was the topic "Global Pharmaceutical Market Outlook: 2015." This presentation is mainly about the quantification of the impact of multiple dynamics and examining the spending and usage of medicines in 2015, globally and for specific therapy areas and countries. The other one was about "Pharma Licensing - Case Studies & Pointers," shared by Dr. Richie Paul, the Director of Intellectual Property from Elan Drug Technologies. He analysed 4 cases and proposed that technology providers could play a role in both enabling NCE-based products and lifecycle Management. If you are interested in them, please CLICK HERE to download for free.

If you cannot download successfully, please use this link:
http://www.pharmaip-forum.com/Download.aspx?id=16&lang=en-us&source=pr2

Media Contact

Ms. Tracy Cui
Tel: +86-21-6157 3919
Fax:+86-21-6157 7299
Email: tracy.cui@ubm.com


'/>"/>
SOURCE UBM Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Key Considerations for Selecting and Implementing a CAD/CAM System for Dental Laboratories Outlined in Free Article Download from Jensen Dental
2. Mobile MIM for Diagnostic Imaging Surpasses 250,000 Downloads
3. Free Download -- QbD Implementation for Pharma Companies
4. Free Download: Two Impressive Case Studies on Drug Delivery Discoveries
5. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
6. Hydrogel Implant GelrinC Demonstrates Impressive Recovery Rates for Patients with Knee Cartilage Damage
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
9. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
10. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
11. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):